Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Digital Health and Artificial Intelligence: Advancing Healthcare Provision in Latin America

Garcia Alonso R, Thoene U, Davila Benavides D. Institute of Electrical and Electronics Engineers (IEEE). IT Professional. 2022; 24 (2) : 62-68.
Publication

A safe, effective, and reliable vaccine against Chagas disease should be described!

Silva JS. FapUNIFESP (SciELO). Memórias do Instituto Oswaldo Cruz. 2022;
Download PDF
Publication

Cohort Profile: The 100 Million Brazilian Cohort

Barreto ML, Ichihara MY, Pescarini JM, et al. Oxford University Press (OUP). International Journal of Epidemiology. 2021; 51 (2) : e27-e38.
Download PDF
Publication

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease

Macedo AM, Pena SD. FapUNIFESP (SciELO). Memórias do Instituto Oswaldo Cruz. 2022;
Download PDF
Publication

Neglected Tropical Diseases (NTDs) and COVID-19 Pandemic in Africa: Special Focus on Control Strategies

Aborode AT, Fajemisin EA, Aiyenuro EA, et al. Bentham Science Publishers Ltd.. Combinatorial Chemistry & High Throughput Screening. 2022;
Publication

Target Product Profile for the detection of a case of yaws and the detection of azithromycin resistance

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

Target Product Profile for a rapid test for diagnosis of mycetoma at the primary health-care level

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

Krolewiecki A, Enbiale W, Gandasegui J, et al. F1000 Research Ltd. Gates Open Research. 2022;
Download PDF
Publication

Strengthening preparedness against global health threats: A paradigm shift based on One Health approaches

Dente M, Riccardo F, Declich S, et al. Elsevier BV. One Health. 2022;
Download PDF
Publication

The European and Developing Countries Clinical Trials Partnership (EDCTP) Knowledge Hub: developing an open platform for facilitating high-quality clinical research

Driver S, Gray S, Sikhondze W, et al. Springer Science and Business Media LLC. Trials. 2022;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 369
  • Page 370
  • Page 371
  • Page 372
  • Current page 373
  • Page 374
  • Page 375
  • Page 376
  • Page 377
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD